Altre lingue Elanco Animal Health Incorporated

Azioni

ELAN

US28414H1032

Prodotti farmaceutici

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 06/02/2026			Variaz. 5gg	Var. 1 gen.
25,20 ^USD	+3,66%		+4,65%	+11,36%

29/01	ELANCO ANIMAL HEALTH INCORPORATED : da UBS è Buy	ZM
22/01	Le azioni di Elanco Animal Health salgono dopo il miglioramento del rating da parte di Piper Sandler	MT

Altre lingue

22/01	Elanco Animal Health Shares Rise After Piper Sandler Upgrade
22/01	Escalate, De-Escalate, Repeat
22/01	Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement
22/01	Analyst recommendations: Datadog, Albemarle, Halliburton, Netflix…
13/01	Elanco CEO: Gaining Market Share Via 'Major' Innovations
06/01	Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference
31/12	Elanco Animal Health Gets USDA Approval for Canine-Dermatitis Treatment
31/12	Elanco Animal Health Secures USDA Approval for Befrena Targeting Canine Allergic and Atopic Dermatitis
31/12	Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis
31/12	Elanco Animal Health Incorporated Receives USDA Approval for Befrena?? (tirnovetmab)
27/12	3 géants français…et leur comparable américain méconnu
18/12	Elanco's Credelio Quattro??-CA1 (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs
18/12	Elanco Says Credelio Quattro-CA1 Got FDA Conditional Approval for Treatment of New World Screwworm in Dogs
18/12	Elanco's Credelio Quattro(TM)-Ca1 receives first FDA conditional approval
18/12	Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs
16/12	L'Europe termine en repli après l'emploi américain
16/12	Virbac : fait l'acquisition d'un traitement pour 114 millions d'euros
16/12	Virbac acquiert un médicament pour l'hyperthyroïdie féline auprès de Norbrook pour £100 mlns
16/12	Virbac acquiert les droits de distribution d'un médicament pour stabiliser l'hyperthyroïdie féline
16/12	Virbac SA acquired Thyronorm from Norbrook Laboratories Limited in a transaction valued at ?100 million.
15/12	Elanco Animal Health Incorporated : Announces Full USDA Approval of CPMA (Now Trutect™) the First-and-Only Treatment for Deadly Canine Parvovirus
09/12	Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
09/12	Elanco Animal Health Incorporated Announces Organizational Changes
09/12	Elanco Animal Health Incorporated Announces Continued Investment in Its U.S. Operations, Workforce and Communities over the Next Five Years
09/12	Elanco Animal Health Incorporated Announces Significant Progress in the Final Steps of the Approval of Befrena?

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Filtri

Ultime notizie

I farmaci di punta trainano il business di Elanco, afferma l'amministratore delegato

09 settembre 2025 alle 18:36